Alzheimer's Treatment

Your Alzheimer’s Questions Answered: Q&A with Rudy Tanzi

Posted: Apr. 17, 2014

We collected your questions about Alzheimer's from our fall symposium and social media and presented them to Dr. Rudy Tanzi, chairman of our Research Consortium. Watch the videos below!

Drug Development Strategy: Three Points of Attack

Posted: Jan. 28, 2014

In view of an emerging consensus on how Alzheimer’s disease develops and progresses, the Cure Alzheimer’s Fund Research Consortium aggressively is focusing on three opportunities for possible intervention—at the early stage of the disease, the middle stage and the late stage. This comprehensive strategy addresses the whole picture of how Alzheimer’s disease develops and progresses, and attacks all three points simultaneously.

Desperate For a Cure: The Search for New Alzheimer's Treatments

Posted: Oct. 4, 2013

"Desperate For A Cure: The Search For New Alzheimer's Treatments", a new five-part series by NPR's Sean Corcoran, aired this week on WCAI and will air again next week on WGBH in Boston.

Drs. Sam Gandy and Scott Noggle Receive NIH Grant

Posted: Sep. 19, 2013

Drs. Sam Gandy and Scott Noggle have received an NIH grant to gain new insights and identify potential therapies for Alzheimer’s disease.

Cholesterol and Alzheimer's: A Big Step Forward

Posted: Jul. 29, 2013

For several years now, researchers have been aware of important links between cholesterol and Alzheimer's disease. A new study by Dr. Dora Kovacs and her team at Massachusetts General Hospital brings us one step closer to a potential drug that could interrupt the disease process.

Targretin Fails: High Hopes Dashed for a New Treatment for Alzheimer’s

Posted: May 24, 2013

While many were anxious to accept initial findings showing a drug known as Targretin’s “too good to be true” lab results with Alzheimer’s disease, subsequent attempts to confirm and replicate the original data regarding the ability of Targretin to remove amyloid plaques, the cardinal lesion of the disease, have largely failed. Cure Alzheimer’s Fund Research Consortium members Dr. Sangram Sisodia, professor of neuroscience at the University of Chicago and Dr.